Cycle physiology
What is the luteal phase?
Your menstrual cycle has two main phases. The follicular phase runs from the first day of your period to ovulation. The luteal phase runs from ovulation to the day before your next period.
After the egg is released, the empty follicle becomes a temporary hormone producing structure called the corpus luteum. Its main job is to make progesterone, which helps prepare the uterine lining for a possible pregnancy.
A typical luteal phase is about 12 to 14 days, with a commonly cited range of 11 to 17 days. A luteal phase shorter than 10 days is often described as short, although definitions vary across studies.1
The evidence gap
Is this even a real diagnosis?
It is a real finding, but a controversial diagnosis. There are several reasons for that.
It occurs in fertile women
Research summarized by the American Society for Reproductive Medicine found luteal phases under 10 days in about 9% to 13% of ovulatory cycles among normally menstruating women. A shorter luteal phase was not associated with lower overall fertility at 12 months.1
It has not been proven to cause infertility
Luteal phase deficiency has not been shown to be an independent cause of infertility or recurrent pregnancy loss in natural cycles.1
Cycle length can vary
One short cycle does not establish a persistent problem. Tracking more than one cycle can provide a more useful pattern.
A short luteal phase may be a clue that something affecting ovulation or follicle development deserves attention. It is not necessarily a disease on its own.
Timing matters
How a short luteal phase is assessed
In the clinic
Mid luteal progesterone. This blood test can provide evidence that ovulation occurred. It is best timed about one week before the expected period, often six to eight days after ovulation. The familiar “Day 21” timing only fits a 28 day cycle. For a 35 day cycle, testing may be closer to Day 28.
Progesterone is released in pulses and can change substantially within a few hours. A single result can support that recent ovulation occurred, but it cannot reliably assess the quality of the luteal phase, and no single minimum value defines a fertile luteal phase.1, 2
“Day 21” is only correct for a 28 day cycle
The sample should be timed to the individual cycle, approximately seven days before the next period is expected, rather than automatically drawn on cycle Day 21.1, 2
| Cycle length | Approximate day to draw |
|---|---|
| 28 days | Day 21 |
| 30 days | Day 23 |
| 35 days | Day 28 |
| Irregular cycles | Use the expected period or estimated ovulation to guide timing. If using an LH kit, remember that the surge usually precedes ovulation by one to two days. |
Commonly used thresholds and their limits
Canadian laboratories report different luteal phase reference intervals, partly because methods and analyzer platforms differ. Values such as 16 nmol/L and 30 nmol/L appear in clinical practice, but they are conventions rather than validated cutoffs for diagnosing luteal phase deficiency.1, 7, 8, 9
| Result or convention | What it may support | Important limitation |
|---|---|---|
| 9.5 nmol/L or lower | Recent ovulation is not confirmed by this sample. | A low value can reflect anovulation, incorrect timing, or normal pulsatile variation. It should not be interpreted alone. |
| Above 9.5 nmol/L | This is equivalent to more than 3 ng/mL and provides presumptive evidence of recent ovulation. | It does not establish adequate corpus luteum function or predict fertility. |
| 16 nmol/L | This is near the lower limit of some Canadian mid luteal laboratory intervals and is sometimes used as a practical ovulation threshold. | Other Canadian laboratory intervals begin lower or higher. This value does not diagnose luteal phase deficiency. |
| 30 nmol/L | This is often treated as reassuring or consistent with ovulation in clinical practice. | No single progesterone value has been validated as proof of adequate or fertile luteal function. |
First confirm that the sample was timed correctly. Then compare the result with the performing laboratory's reference interval. Use a single value mainly as evidence for or against recent ovulation, not as a grade of luteal quality. If the result is low or does not fit the cycle history, consider repeating it with better timing and evaluate possible contributors such as thyroid dysfunction, hyperprolactinemia, or ovulatory dysfunction when clinically indicated.1, 2
Ultrasound. Follicle tracking can provide evidence of ovulation and corpus luteum formation. It may be useful in selected cases but is not routinely required for every concern about luteal length.2
At home
LH ovulation predictor kits. These detect the urinary LH surge. Ovulation may occur at any point in the two days after the surge. Counting from estimated ovulation to the day before the next period can help estimate luteal phase length.3
Basal body temperature. Progesterone causes a small rise in resting temperature after ovulation. Daily charting may show a two phase pattern and help identify the luteal phase retrospectively. It is inexpensive, but sleep disruption, shift work, illness, alcohol, and inconsistent timing can reduce its reliability. Professional guidance does not recommend it routinely when the menstrual history already suggests regular ovulation.2
Using an LH kit with a temperature chart can provide a fuller pattern than relying on an app prediction alone. Neither method proves luteal phase deficiency. Bring your charts to your appointment because they can help a clinician time any blood work more accurately.
A different clinical question
What about Day 3 FSH and LH?
Day 3 hormone tests do not diagnose a short luteal phase. Early follicular FSH is sometimes assessed with estradiol when ovarian reserve information is clinically relevant. A higher FSH may be associated with diminished ovarian reserve, but one result must be interpreted in the context of age, history, ultrasound findings, and other testing. A normal FSH does not guarantee normal ovarian reserve or fertility.2
FSH, LH, and estradiol can also help investigate absent or very irregular periods. Low or normal FSH with low estradiol may suggest hypothalamic suppression, while high FSH with low estradiol may suggest ovarian insufficiency. The LH to FSH ratio is not a stand alone diagnostic test for PCOS.2, 5
Look upstream
Why thyroid, prolactin, energy balance, and metabolic health matter
The luteal phase depends on the follicle that developed before ovulation. Conditions that alter the brain, pituitary, and ovary signals involved in follicle development can also affect corpus luteum function.
Untreated thyroid disorders can affect cycles and ovulation. TSH testing is most useful when symptoms, irregular cycles, or the clinical history support it.
High prolactin can suppress the hormone signals needed for ovulation. Testing is especially relevant with absent or irregular periods, milk discharge outside pregnancy, or other suggestive symptoms.
Low energy intake, significant weight change, or intense exercise can suppress reproductive hormone signalling and disrupt ovulation.
Insulin resistance and PCOS can affect follicle development and ovulation. Assessment should be individualized and free from assumptions based on body size alone.
Other possible contributors include perimenopausal changes, some medications, chronic illness, significant stress, and conditions that affect ovulation. The first clinical task is to identify and address a relevant underlying cause rather than treating a short luteal phase in isolation.1, 2
Treatment uncertainty
Does vaginal progesterone help?
The honest answer is that we do not know whether it improves live birth for a presumed luteal phase problem in a natural cycle.
- There are no high quality randomized trials showing that progesterone improves outcomes specifically for luteal phase deficiency in natural, unstimulated cycles.1
- A 2022 Cochrane review found uncertainty about whether vaginal progesterone improves live birth or ongoing pregnancy in women trying to conceive through intercourse or intrauterine insemination. Much of the available evidence involved ovarian stimulation or insemination rather than untreated natural cycles.4
- Progesterone support has an established role in assisted reproduction, but evidence from IVF or frozen embryo transfer should not automatically be applied to natural conception.
Vaginal progesterone is generally well tolerated, but it is not risk free and should be prescribed after an individualized discussion of possible benefits, uncertainty, side effects, and alternatives. Vaginal irritation and discharge can occur. In Canada, available progesterone products and routes have specific approved indications. Fertility use may be off label depending on the product, route, and reason for treatment.6
Treat the clinical problem
Other treatments that may help
- 1Treat an identified cause.
Management may include thyroid treatment, care for elevated prolactin, medication review, or nutrition and exercise changes when energy availability is affecting ovulation.
- 2Improve ovulation when indicated.
Clomiphene and letrozole can support follicle development in selected patients. For anovulatory infertility associated with PCOS and no other infertility factors, current international guidance recommends letrozole as first line pharmacologic treatment.5
- 3Complete a broader fertility assessment.
A semen analysis and, when indicated, assessment of the uterus and fallopian tubes can identify important factors that luteal phase testing cannot.
Do not rely on an app alone
When to seek a full fertility evaluation
Seek assessment sooner for absent or very irregular periods, suspected endometriosis or tubal disease, prior pelvic surgery, recurrent pregnancy loss, known male factor concerns, sexual dysfunction, or another condition known to affect fertility. Evaluation should begin with both partners when applicable.2, 3
If you have only been trying for a few months and your cycles are otherwise regular, a short luteal phase estimated by an app is not a reason to panic. Track the pattern, note how ovulation was estimated, and discuss persistent concerns with a clinician.
The bottom line
A short luteal phase is a clue, not a complete explanation.
- A short luteal phase is measurable and relatively common, but it is not proven to cause infertility on its own.
- Cycle tracking can show a pattern. Well timed progesterone testing can support that ovulation occurred, but no single result grades luteal phase quality.
- The most useful next step is often to look for an underlying cause involving ovulation, thyroid function, prolactin, energy availability, metabolic health, or PCOS.
- Vaginal progesterone is sometimes offered, but benefit in natural conception cycles remains uncertain.
- Bring your tracking data to a clinician who can interpret it in the context of the full fertility picture.
Sources and review notes
Evidence used in this article
This article prioritizes professional society guidance, a Cochrane systematic review, and Canadian regulatory information. Evidence was reviewed October 1, 2026. Recommendations can change, and individual care depends on history, medications, goals, and jurisdiction.
- ASRM: Diagnosis and treatment of luteal phase deficiency
- ASRM: Fertility evaluation of infertile women
- ASRM: Optimizing natural fertility
- Cochrane Review: Luteal phase support for women trying to conceive
- International evidence based guideline for polycystic ovary syndrome
- Health Canada: Prometrium product information
- Medical Council of Canada: Canadian normal laboratory values
- London Health Sciences Centre: Progesterone reference intervals
- University Health Network: Progesterone laboratory reference ranges
A focused next step
Turn cycle data into a clinically useful plan.
Asali Health provides clinician referred virtual reproductive health and fertility consultations in Ontario and British Columbia.